Furthermore, recent investigative findings indicate that indole-3-lactic acid (IPA), a compound produced by bacteria, can augment the efficacy of αPD-1 immunotherapy mediated by CD8 + T cells in the treatment of diverse neoplasms, including melanoma, breast cancer, and colorectal carcinoma. The gene discussed is CD8A; the disease is neoplasm.